WO2003057215A1 - Accelerateur de production/secretion de facteur neurotrophique - Google Patents

Accelerateur de production/secretion de facteur neurotrophique Download PDF

Info

Publication number
WO2003057215A1
WO2003057215A1 PCT/JP2002/013654 JP0213654W WO03057215A1 WO 2003057215 A1 WO2003057215 A1 WO 2003057215A1 JP 0213654 W JP0213654 W JP 0213654W WO 03057215 A1 WO03057215 A1 WO 03057215A1
Authority
WO
WIPO (PCT)
Prior art keywords
optionally substituted
neurotrophic factor
factor production
group
secretion accelerator
Prior art date
Application number
PCT/JP2002/013654
Other languages
English (en)
Japanese (ja)
Inventor
Masatoshi Hazama
Norihisa Iwakami
Takeshi Miyazaki
Nozomu Sakai
Tsuyoshi Maekawa
Yu Momose
Toru Kawamura
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Priority to AU2002367426A priority Critical patent/AU2002367426A1/en
Publication of WO2003057215A1 publication Critical patent/WO2003057215A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

L'invention concerne un accélérateur de production/sécrétion de facteur neurotrophique, contenant un composé représenté par la formule générale (I), dans laquelle un des restes R1 et R2 désigne hydrogène ou un substituant et l'autre représente un groupe cyclique éventuellement substitué ; W désigne une liaison ou un groupe hydrocarbure aliphatique bivalent ; et Y désigne un groupe représenté par la formule OR3 (R3 désigne hydrogène ou un groupe hydrocarbure éventuellement substitué, un groupe hétérocyclique éventuellement substitué ou acyle éventuellement substitué) ou carboxyle éventuellement estérifié ou amidé, un sel du composé ou un promédicament de l'un ou de l'autre. Ledit composé représenté par la formule générale (I) présente une excellente activité et est de toxicité réduite.
PCT/JP2002/013654 2001-12-28 2002-12-26 Accelerateur de production/secretion de facteur neurotrophique WO2003057215A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002367426A AU2002367426A1 (en) 2001-12-28 2002-12-26 Neurotrophic factor production/secretion accelerator

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001401380 2001-12-28
JP2001-401380 2001-12-28

Publications (1)

Publication Number Publication Date
WO2003057215A1 true WO2003057215A1 (fr) 2003-07-17

Family

ID=19189767

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/013654 WO2003057215A1 (fr) 2001-12-28 2002-12-26 Accelerateur de production/secretion de facteur neurotrophique

Country Status (2)

Country Link
AU (1) AU2002367426A1 (fr)
WO (1) WO2003057215A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007502817A (ja) * 2003-08-20 2007-02-15 イーライ リリー アンド カンパニー グルカゴン様ペプチド（ｇｌｐ）−１化合物またはメラノコルチン４受容体（ｍｃ４）アゴニストペプチドの経口デリバリーのための化合物、方法および製剤
US7470715B2 (en) 2005-12-22 2008-12-30 Pfizer Inc. Estrogen modulators
US8304438B2 (en) 2006-12-20 2012-11-06 Sanofi Heteroarylacrylamides and their use as pharmaceuticals
US8552039B2 (en) 2003-08-20 2013-10-08 Emisphere Technologies, Inc. Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
US8604069B2 (en) 2011-04-28 2013-12-10 Japan Tobacco Inc. Amide compound and medicinal use thereof
CN113480489A (zh) * 2021-08-19 2021-10-08 贵州大学 异噁唑联苯类化合物及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0517354A (ja) * 1991-07-03 1993-01-26 Nichiban Co Ltd イソキサゾ−ル誘導体含有経皮吸収製剤
JPH08175992A (ja) * 1994-12-21 1996-07-09 Sagami Chem Res Center 神経成長因子産生促進剤および縮環型オキサゾール化合物
WO2001014372A2 (fr) * 1999-08-25 2001-03-01 Takeda Chemical Industries, Ltd. Agent promoteur de la production/secretion de neurotrophine
WO2002040458A1 (fr) * 2000-11-17 2002-05-23 Takeda Chemical Industries, Ltd. Derives d'isoxazole
JP2003081831A (ja) * 2001-06-26 2003-03-19 Takeda Chem Ind Ltd ＴＧＦ−βスーパーファミリー産生・分泌促進剤

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0517354A (ja) * 1991-07-03 1993-01-26 Nichiban Co Ltd イソキサゾ−ル誘導体含有経皮吸収製剤
JPH08175992A (ja) * 1994-12-21 1996-07-09 Sagami Chem Res Center 神経成長因子産生促進剤および縮環型オキサゾール化合物
WO2001014372A2 (fr) * 1999-08-25 2001-03-01 Takeda Chemical Industries, Ltd. Agent promoteur de la production/secretion de neurotrophine
WO2002040458A1 (fr) * 2000-11-17 2002-05-23 Takeda Chemical Industries, Ltd. Derives d'isoxazole
JP2003081831A (ja) * 2001-06-26 2003-03-19 Takeda Chem Ind Ltd ＴＧＦ−βスーパーファミリー産生・分泌促進剤

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRAIN RESEARCH. MOLECULAR BRAIN RESEARCH, vol. 18, no. 3, 1993, pages 201 - 208 *
DATABASE MEDLINE [online] "Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease", XP002965288, accession no. STN Database accession no. 1999167108 *
DATABASE MEDLINE [online] "Glutamate receptor agonists enhance the expression of BDNF mRNA in cultured cerebellar granule cells", XP002965289, accession no. STN Database accession no. 93268074 *
KATOH-SEMBA R. ET AL.: "Induction of brain-derived neurotrophic factor by convulsant drugs in the rat brain: involvement of region-specific voltage-dependent calcium channels", JOURNAL OF NEUROCHEMISTRY, vol. 77, no. 1, 2000, pages 71 - 83, XP002965287 *
NEUROBIOLOGY OF DISEASE, vol. 5, no. 5, 1998, pages 357 - 364 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007502817A (ja) * 2003-08-20 2007-02-15 イーライ リリー アンド カンパニー グルカゴン様ペプチド（ｇｌｐ）−１化合物またはメラノコルチン４受容体（ｍｃ４）アゴニストペプチドの経口デリバリーのための化合物、方法および製剤
US7947841B2 (en) 2003-08-20 2011-05-24 Emisphere Technologies, Inc. Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
JP4754487B2 (ja) * 2003-08-20 2011-08-24 エミスフィアー テクノロジーズ インコーポレイテッド グルカゴン様ペプチド（ｇｌｐ）−１化合物またはメラノコルチン４受容体（ｍｃ４）アゴニストペプチドの経口デリバリーのための化合物、方法および製剤
US8546581B2 (en) 2003-08-20 2013-10-01 Emisphere Technologies, Inc. Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
US8552039B2 (en) 2003-08-20 2013-10-08 Emisphere Technologies, Inc. Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
US8765796B2 (en) 2003-08-20 2014-07-01 Emisphere Technologies, Inc. Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
US7470715B2 (en) 2005-12-22 2008-12-30 Pfizer Inc. Estrogen modulators
US8304438B2 (en) 2006-12-20 2012-11-06 Sanofi Heteroarylacrylamides and their use as pharmaceuticals
US8604069B2 (en) 2011-04-28 2013-12-10 Japan Tobacco Inc. Amide compound and medicinal use thereof
CN113480489A (zh) * 2021-08-19 2021-10-08 贵州大学 异噁唑联苯类化合物及其制备方法和应用

Also Published As

Publication number Publication date
AU2002367426A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
AU3461697A (en) Heterocyclic compounds, their production and use
WO2002100812A1 (fr) Dérivé de l'acide carboxylique et son sel
WO2004024777A8 (fr) Derives d'amidon hydroxyalkyle
EP1394147A4 (fr) Derive de l'acide carboxylique et medicament comprenant un sel ou un ester dudit derive
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
CA2173150A1 (fr) Nouveau derive peptidique
CA2418770A1 (fr) Compose acylacetonitrile, processus de preparation, et acaricide contenant ce compose
WO2003046034A3 (fr) Synthese amelioree de polyanhyrides
EP1582521A4 (fr) Compose de furane condense
WO1999009965A3 (fr) Agent antiinflammatoire
EP1291344A4 (fr) Agents de controle de la piriculariose du riz
WO2003035620A1 (fr) Compose bicyclique
MXPA05013631A (es) Derivado heterociclico de metilsulfona.
WO2003059907A1 (fr) Composes heterocycliques azotes : procede de preparation et d'utilisation
WO2003004497A1 (fr) Compose heterocyclique
IE901350L (en) Diaminoethylene compounds
WO2002000638A3 (fr) Nouveaux phthalides substitues, leur procede de preparation et compositions pharmaceutiques les contenant
WO2003057215A1 (fr) Accelerateur de production/secretion de facteur neurotrophique
WO2003035650A1 (fr) Inhibiteur d'entree
EP1550651A4 (fr) Derive glycerol
DE60230781D1 (en) Reverse hydroxamsäurederivate
EP1661898A4 (fr) Compose de piperazine bicyclique et utilisation de ce dernier
EP1174421A4 (fr) Derives de 3-amidinobenzenesulfonamide, compositions medicales qui les contiennent, et produits intermediaires pour leur elaboration
EP1346994A4 (fr) Inhibiteurs de la biosynthese du cholesterol contenant comme principe actif des composes spiro tricycliques
EP1310490A4 (fr) Antagoniste de gpr14

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP